2010 Annual Report
1a.Objectives (from AD-416)
Determine the bioavailability of encapsulated pterostilbene using encapsulation technology developed by Food Science and Technology, Australia (FSA)
1b.Approach (from AD-416)
Pterostilbene will be synthesized then encapsulated. Encapsulated pterostilbene will be administered to mice/rats. Levels of pterostilbene in mouse/rat serum will be determined.
This project is tied with Agreement Number: 6408-41000-006-11N. The objective of the project is to determine the bioavailability of encapsulated pterostilbene using encapsulation technology developed by FSA. Collaborators at FSA successfully encapsulated pterostilbene sent to them. Encapsulated pterostilbene was sent back to Natural Products Utilization Research Unit (NPURU), and is now being administered to mice. Methods used for monitoring or discussing research progress were by telephone call and email.